ArticleNanomedicine (London, England)2026
Astragaloside IV and rapamycin co-loaded bone marrow mesenchymal stem cell-derived exosome nanocarriers for targeted modulation of the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.